| Dr Cathryn A Fogel, MD | |
|
111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 | |
| (860) 282-4137 | |
| (860) 282-0170 |
| Full Name | Dr Cathryn A Fogel |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 111 Founders Plz, East Hartford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881685766 | NPI | - | NPPES |
| 001353812 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 035381 (Connecticut) | Primary |
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407806391 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000700 |
News Archive
Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.
Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.
A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.
Fibrocell Science, Inc. announced today that the Company has completed a private placement with certain accredited investors, pursuant to which the Company sold to the purchasers an aggregate of 41,409,458 shares of Company common stock at a purchase price of $0.55 per share.
The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.
› Verified 3 days ago
| Entity Name | Hartford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770696643 PECOS PAC ID: 2567366016 Enrollment ID: O20031125000752 |
News Archive
Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.
Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.
A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.
Fibrocell Science, Inc. announced today that the Company has completed a private placement with certain accredited investors, pursuant to which the Company sold to the purchasers an aggregate of 41,409,458 shares of Company common stock at a purchase price of $0.55 per share.
The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.
› Verified 3 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.
Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.
A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.
Fibrocell Science, Inc. announced today that the Company has completed a private placement with certain accredited investors, pursuant to which the Company sold to the purchasers an aggregate of 41,409,458 shares of Company common stock at a purchase price of $0.55 per share.
The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cathryn A Fogel, MD 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 Ph: (860) 282-4137 | Dr Cathryn A Fogel, MD 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108-3212 Ph: (860) 282-4137 |
News Archive
Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.
Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.
A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.
Fibrocell Science, Inc. announced today that the Company has completed a private placement with certain accredited investors, pursuant to which the Company sold to the purchasers an aggregate of 41,409,458 shares of Company common stock at a purchase price of $0.55 per share.
The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.
› Verified 3 days ago
Dr. Sung-chil Hong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Marc Andre Paradis, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Alexander S. Peck Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Peter H Diamond, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 99 E River Dr, 5th Floor, East Hartford, CT 06108 Phone: 860-282-4022 Fax: 860-289-0746 | |
Dr. Leslie S Kish, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Nancy J Weinstein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Dr. Michael Anthony Miranda Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 |